☰

Empresas y finanzas

ICON Issues Financial Guidance for 2008 and Reaffirms Guidance for 2007


    ICON (NASDAQ:ICLR), a global provider of outsourced development
    services to the pharmaceutical, biotechnology and medical device
    industries, today announced financial guidance for 2008.

    2008 net revenue is expected to be in the range of $750 - $770
    million, compared to a range of $615 - $625 million which has already
    been guided for 2007.

    2008 net income per diluted share is forecast to be in the range
    of $2.27 - $2.36 compared to $1.82 - $1.85 guided for 2007.

    The company will hold a conference call today, December 19, 2007
    at 09:00 EST (14:00 Ireland & UK). A question and answer session will
    follow.

    The statements made in this Press Release may contain
    forward-looking statements that involve a number of risks and
    uncertainties. In addition to the matters described in this Press
    Release, the ability to maintain large client contracts or enter into
    new contracts, maintain client relationships and the ability to manage
    the opening of new offices, the integration of new business mergers
    and acquisitions, as well as other risks and uncertainties detailed
    from time to time in SEC reports filed by ICON, including its Form
    20-F, F-1, S-8 and F-3, may affect the actual results achieved by
    ICON. ICON disclaims any intent or obligation to update these
    forward-looking statements.

    The financial information presented herein has been prepared in
    accordance with U.S. GAAP.

    ICON plc is a global provider of outsourced development services
    to the pharmaceutical, biotechnology and medical device industries.
    The Company specializes in the strategic development, management and
    analysis of programs that support clinical development - from compound
    selection to Phase I-IV clinical studies. ICON teams have successfully
    conducted over 1,900 development projects and over 2,300 consultancy
    engagements across all major therapeutic areas. ICON currently has
    approximately 5,600 employees, operating from 67 locations in 35
    countries. Further information is available at www.iconplc.com.

    Source: ICON plc